| Clinical data | |
|---|---|
| Pronunciation | ⓘ |
| Trade names | Cipralex, Lexapro, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a603005 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| Drug class | Selective serotonin reuptake inhibitor |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 80% |
| Protein binding | ~56% |
| Metabolism | Liver, specifically the enzymes CYP3A4 and CYP2C19 |
| Elimination half-life | 27–32 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.244.188 |
| Chemical and physical data | |
| Formula | C20H21FN2O |
| Molar mass | 324.392 g/mol (414.43 as oxalate) |
| 3D model (JSmol) | |
| |
| |
| | |

Escitalopram is an antidepressant medication. It is used as a drug to help treat depression, obsessive-compulsive disorder, social anxiety disorder and other mental illnesses. It is commonly known and sold as Lexapro or Cipralex.
Escitalopram can cause sleeping problems, dry mouth and diarrhea. It can also cause sexual problems. These sexual problems usually disappear after a person stops using the drug. However, in some cases these problems can last for months or years.